Appia Bio
Allogeneic Cell Therapies for Cancer
5 open rolesAllogeneic Cell Therapies for CancerLos Angeles, United States36 employees$52M raisedEst. 2020
About Appia Bio
- Appia Bio was an early-stage biotechnology company based in Los Angeles, California, founded in 2020.
- It focused on discovering and developing off-the-shelf allogeneic cell therapies from hematopoietic stem cells for cancer patients.
- The company shut down its operations in August 2023 due to funding issues.
Appia Bio is listed on Rocketlist with 5 active roles. The company is categorized as Allogeneic Cell Therapies for Cancer in BioTech. Appia Bio is at Series A stage, with a B2B business model, headquartered in Los Angeles, United States. Appia Bio was founded in 2020 and has 36 employees. Appia Bio has raised $52M. Active roles are refreshed daily from public hiring sources.